June Sherie Almenoff - 10 Nov 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Christopher R. Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
10 Nov 2021
Transactions value $
$0
Form type
4
Date filed
12 Nov 2021, 15:18
Previous filing
15 Jun 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +80K $0.00 80K 10 Nov 2021 Common Stock 80K $2.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest in three substantially equal installments on November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service on each such vesting date.